Author details

Full Name

Robert Canfield

Affiliation

ORCID

Career Start Year

1957

Papers

144

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36356032	Protein prediction models support widespread post-transcriptional regulation of protein abundance by interacting partners.	PLoS Comput Biol	2022
35347217	Structural and mechanistic basis for redox sensing by the cyanobacterial transcription regulator RexT.	Communications Biology	2022
15665026	Intact HCG, free HCG beta subunit and HCG beta core fragment: longitudinal patterns in urine during early pregnancy.	Human Reproduction	2005
12573104	Isolation of native human monoclonal autoantibodies to breast cancer.	Hybrid Hybridomics	2002
9895397	Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network.	N Engl J Med	1999
10451222	Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG.	Endocrine	1999
9531868	Measuring human chorionic gonadotropin in the absence of implantation with use of highly sensitive urinary assays for intact beta-core and free beta epitopes.	Fertility and Sterility	1998
9619532	The expression of the urinary forms of human luteinizing hormone beta fragment in various populations as assessed by a specific immunoradiometric assay.	Human Reproduction	1998
8688417	Structural and conformational analysis of glycan moieties in situ on isotopically 13C, 15N-enriched recombinant human chorionic gonadotropin.	Biochemistry	1996
9027340	Three-dimensional structures of gonadotropins.	Mol Cell Endocrinol	1996
8765736	Expression of human chorionic gonadotropin uniformly labeled with NMR isotopes in Chinese hamster ovary cells: an advance toward rapid determination of glycoprotein structures.	J Biomol NMR	1996
21153216	HLH beta core fragment immunoreactivity in the urine of ovulating women: a sensitive and specific immunometric assay for its detection.	Endocrine	1995
7835298	The expression, characterization, and crystallization of wild-type and selenomethionyl human chorionic gonadotropin.	Endocrinology	1995
7509735	Development, characterization, and application of monoclonal antibodies to the native and synthetic beta COOH-terminal portion of human chorionic gonadotropin (hCG) that distinguish between the native and desialylated forms of hCG.	Endocrinology	1994
8202136	Crystal structure of human chorionic gonadotropin.	Nature	1994
7922031	Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein.	Structure	1994
7843071	Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements.	Endocrine Reviews	1994
7517717	The development of assays for the detection of fibrin(ogen)olysis based on COOH-terminal A alpha chain epitopes.	Blood	1994
7689962	Structure and significance of human luteinizing hormone-beta core fragment purified from human pituitary extracts.	Endocrinology	1993
8319596	The application of chemical studies of human chorionic gonadotropin to visualize its three-dimensional structure.	Endocrine Reviews	1993
1601143	Prospective assessment of early fetal loss using an immunoenzymometric screening assay for detection of urinary human chorionic gonadotropin.	Fertility and Sterility	1992
18411184	Paget's disease of bone.	Trends in Endocrinology and Metabolism	1991
1910601	Biological markers on human pregnancy.	Biomedical and Environmental Sciences	1991
1705504	Development and characterization of a new, highly specific antibody to the human chorionic gonadotropin-beta fragment.	Endocrinology	1991
1715122	Immunochemical studies of A alpha chain crosslinking.	Advances in Experimental Medicine and Biology	1990
2271566	Isolation and partial structural characterization of an equine fibrinogen CNBr fragment that exhibits immunologic cross-reactivity with an A alpha-chain cross-linking region of human fibrinogen.	Biochemistry	1990
2611225	Crystallization and characterization of human chorionic gonadotropin in chemically deglycosylated and enzymatically desialylated states.	Biochemistry	1989
2718781	Parathyroid function in Paget's disease of bone.	Journal of Bone and Mineral Research	1989
2703517	Gait analysis of patients who have Paget disease.	Journal of Bone and Joint Surgery	1989
2449279	Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.	Cancer Research	1988
3393170	Incidence of early loss of pregnancy.	New England Journal of Medicine	1988
3217917	Immunochemical characterization of crosslinked derivatives isolated from alpha chain oligomers formed during early stages of fibrin crosslinking.	Thrombosis and Haemostasis	1988
3217916	Early alpha chain crosslinking in human fibrin preparations.	Thrombosis and Haemostasis	1988
3202237	Heterogeneity of proteins in commercial preparations of human chorionic gonadotropin (hCG) demonstrated by Western blotting.	American Journal of Reproductive Immunology and Microbiology	1988
2980346	Measuring human chorionic gonadotropin for detection of early pregnancy loss.	Reproductive Toxicology	1988
2454812	Preparation and characterization of antibodies to the urinary fragment of the human chorionic gonadotropin beta-subunit.	Endocrinology	1988
2454811	Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine.	Endocrinology	1988
2452075	Characterization of antisera distinguishing carbohydrate structures in the beta-carboxyl-terminal region of human chorionic gonadotropin.	Endocrinology	1988
2961356	Dichloromethylene diphosphonate action in hematologic and other malignancies.	Bone	1987
3817172	Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay.	Fertility and Sterility	1987
3691439	The use of biochemical assays in epidemiologic studies of reproduction.	Environ Health Perspect	1987
3654658	Characterization of the expression products of recombinant human choriogonadotropin and subunits.	Journal of Biological Chemistry	1987
3319556	Development of an assay for a biomarker of pregnancy and early fetal loss.	Environmental Health Perspectives	1987
3103433	Rationale for diphosphonate therapy in hypercalcemia of malignancy. Introduction.	American Journal of Medicine	1987
3034453	Detection of desialylated forms of human chorionic gonadotropin.	Clinica Chimica Acta	1987
2937467	Development of a radioimmunoassay for the fibrinogen-derived peptide B beta 1-42.	Blood	1986
2411157	Characterization and relative orientation of epitopes for monoclonal antibodies and antisera to human chorionic gonadotropin.	American Journal of Reproductive Immunology and Microbiology	1985
4029425	Measuring early pregnancy loss: laboratory and field methods.	Fertility and Sterility	1985
4019785	Carboxyterminal peptide fragments of the beta subunit are urinary products of the metabolism of desialylated human choriogonadotropin.	Journal of Clinical Investigation	1985
2581113	Monoclonal antibodies to gonadotropin subunits.	Methods in Enzymology	1985